Search

Author/Creator Muri, Dieter

1. Absorption, distribution, metabolism and excretion (ADME) of the ALK inhibitor alectinib: results from an absolute bioavailability and mass balance study in healthy subjects. (4th March 2017)

Authors:
Morcos, Peter N.; Yu, Li; Bogman, Katrijn; Sato, Mika; Katsuki, Hisakazu; Kawashima, Kosuke; Moore, David J; Whayman, Matt; Nieforth, Keith; Heinig, Katja; Guerini, Elena; Muri, Dieter; Martin-Facklam, Meret; Phipps, Alex
Journal:
Xenobiotica
Issue:
Volume 47:Number 3(2017)
Page Start:
217
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P4‐185: First in‐human PET study of 3 novel tau radiopharmaceuticals: [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948. (1st July 2015)

Authors:
Wong, Dean F.; Borroni, Edilio; Kuwabara, Hiroto; George, Noble; Rosenberg, Paul; Lyketsos, Constantine; Resnick, Susan M.; Thambisetty, Madhav; Brasic, James; Gapasin, Lorena; Willis, William; Knust, Henner; Guerard, Melanie; Belli, Sara; Muri, Dieter; Carey, Tracie; Bedding, Alun; Wandel, Chris...
Journal:
Alzheimer's & dementia
Issue:
Volume 11(2015)Supplement 7:Part 18
Page Start:
P850
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗